| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:10:45 -0700 |
| HMDB ID |
HMDB01547 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Corticosterone |
| Description |
Corticosterone is an adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 11,21-Dihydroxypregn-4-ene-3,20-dione
- 11,21-Dihydroxyprogesterone
- 11-Hydroxycorticoaldosterone
- 17-Deoxycortisol
- 4-Pregnene-11 Corticosteron
- Corticosterone
- Kendall'S compound B
- Reichstein'S substance H
|
| Chemical Formula |
C21H30O4 |
| Average Molecular Weight |
346.4605 |
| Monoisotopic Molecular Weight |
346.214409448 |
| IUPAC Name |
(1S,2R,10S,11S,14S,15S,17S)-17-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
| Traditional IUPAC Name |
corticosterone |
| CAS Registry Number |
50-22-6 |
| SMILES |
[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C |
| InChI Identifier |
InChI=1S/C21H30O4/c1-20-8-7-13(23)9-12(20)3-4-14-15-5-6-16(18(25)11-22)21(15,2)10-17(24)19(14)20/h9,14-17,19,22,24H,3-8,10-11H2,1-2H3/t14-,15-,16+,17-,19+,20-,21-/m0/s1 |
| InChI Key |
OMFXVFTZEKFJBZ-HJTSIMOOSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Lipids |
| Class |
Steroids and Steroid Derivatives |
| Sub Class |
Gluco/mineralocorticoids, Progestogins and Derivatives |
| Other Descriptors |
- 11beta-hydroxy steroid(ChEBI)
- 20-oxo steroid(ChEBI)
- 21-hydroxy steroid(ChEBI)
- 3-oxo steroid(ChEBI)
- Aliphatic Homopolycyclic Compounds
- C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives(KEGG)
- C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives(Lipidmaps)
- C21-steroid(ChEBI)
- Mineralocorticoids(KEGG)
- Pregnane and derivatives [Fig](KEGG)
- glucocorticoid(ChEBI)
|
| Substituents |
- 11 Hydroxy Steroid
- 20 Keto Steroid
- 3 Keto Steroid
- Alpha Ketoaldehyde
- Cyclic Alcohol
- Cyclohexane
- Cyclohexene
- Decaline
- Ketone
- Primary Alcohol
- Secondary Alcohol
|
| Direct Parent |
Gluco/mineralocorticoids, Progestogins and Derivatives |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Cell signaling
- Component of C21-Steroid hormone metabolism
- Fuel and energy storage
- Fuel or energy source
- Membrane integrity/stability
|
| Application |
- Nutrients
- Stabilizers
- Surfactants and Emulsifiers
|
| Cellular locations |
- Cytoplasm
- Extracellular
- Membrane
- Mitochondria
- Endoplasmic reticulum
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
179 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
0.199 mg/mL |
Not Available |
| LogP |
1.94 |
HANSCH,C ET AL. (1995) |
|
| Predicted Properties |
|
| Spectra |
|
|
| Biological Properties |
| Cellular Locations |
- Cytoplasm
- Extracellular
- Membrane
- Mitochondria
- Endoplasmic reticulum
|
| Biofluid Locations |
|
| Tissue Location |
- Adipose Tissue
- Adrenal Cortex
- Adrenal Gland
- Brain
- Epidermis
- Fibroblasts
- Gonads
- Hypothalamus
- Intestine
- Kidney
- Liver
- Nerve Cells
- Neuron
- Placenta
- Platelet
- Spleen
- Stratum Corneum
- Testes
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.027 +/- 0.005 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.023 +/- 0.0034 uM |
Adult (>18 years old) |
Both |
Depersonalization syndrome |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Depersonalization disorder |
- Nuller YL, Morozova MG, Kushnir ON, Hamper N: Effect of naloxone therapy on depersonalization: a pilot study. J Psychopharmacol. 2001 Jun;15(2):93-5.
Pubmed: 11448093
|
|
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB022684 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
5550  |
| KEGG Compound ID |
C02140  |
| BioCyc ID |
Not Available |
| BiGG ID |
39187  |
| Wikipedia Link |
Corticosterone  |
| NuGOwiki Link |
HMDB01547  |
| Metagene Link |
HMDB01547  |
| METLIN ID |
6314  |
| PubChem Compound |
5753  |
| PDB ID |
C0R  |
| ChEBI ID |
16827  |
| References |
| Synthesis Reference |
Oliveto, Eugene P.; Smith, Herbert Q.; Gerold, Corinne; Rausser, Richard; Hershberg, E. B. 11-Oxygenated steroids. XIV. New syntheses of corticosterone. Journal of the American Chemical Society (1956), 78 1414-16. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Oprica M, Zhu S, Goiny M, Pham TM, Mohammed AH, Winblad B, Bartfai T, Schultzberg M: Transgenic overexpression of interleukin-1 receptor antagonist in the CNS influences behaviour, serum corticosterone and brain monoamines. Brain Behav Immun. 2005 May;19(3):223-34.
Pubmed: 15797311
- Hajdasz P: [Mineralocorticoids in cervical mucous and female blood serum: levels in the preovulatory phase of the menstrual cycle] Ginekol Pol. 2000 Sep;71(9):1007-10.
Pubmed: 11082965
- Ghulam A, Kouach M, Racadot A, Boersma A, Vantyghem MC, Briand G: Quantitative analysis of human serum corticosterone by high-performance liquid chromatography coupled to electrospray ionization mass spectrometry. J Chromatogr B Biomed Sci Appl. 1999 Apr 30;727(1-2):227-33.
Pubmed: 10360442
- Pravosudov VV, Omanska A: Prolonged moderate elevation of corticosterone does not affect hippocampal anatomy or cell proliferation rates in mountain chickadees (Poecile gambeli). J Neurobiol. 2005 Jan;62(1):82-91.
Pubmed: 15389682
- Pardridge WM, Sakiyama R, Judd HL: Protein-bound corticosteroid in human serum is selectively transported into rat brain and liver in vivo. J Clin Endocrinol Metab. 1983 Jul;57(1):160-5.
Pubmed: 6853674
- Kahri AI, Voutilainen R, Salmenpera M: Different biological action of corticosteroids, corticosterone and cortisol, as a base of zonal function of adrenal cortex. Acta Endocrinol (Copenh). 1979 Jun;91(2):329-37.
Pubmed: 223358
- Pruett SB, Fan R, Myers LP, Wu WJ, Collier S: Quantitative analysis of the neuroendocrine-immune axis: linear modeling of the effects of exogenous corticosterone and restraint stress on lymphocyte subpopulations in the spleen and thymus in female B6C3F1 mice. Brain Behav Immun. 2000 Dec;14(4):270-87.
Pubmed: 11120596
- Evans SB, Wilkinson CW, Bentson K, Gronbeck P, Zavosh A, Figlewicz DP: PVN activation is suppressed by repeated hypoglycemia but not antecedent corticosterone in the rat. Am J Physiol Regul Integr Comp Physiol. 2001 Nov;281(5):R1426-36.
Pubmed: 11641112
- Lescoat G, Feliot J, Maniey J: [Evolution of plasma corticosterone concentration in basal conditions or after psychic aggression during growth in the Rat. Influence of neonatal gonadectomy (author's transl)] J Physiol (Paris). 1978 Dec;74(6):591-9.
Pubmed: 570600
- Slominski A, Zbytek B, Semak I, Sweatman T, Wortsman J: CRH stimulates POMC activity and corticosterone production in dermal fibroblasts. J Neuroimmunol. 2005 May;162(1-2):97-102.
Pubmed: 15833364
- Kero J, Poutanen M, Zhang FP, Rahman N, McNicol AM, Nilson JH, Keri RA, Huhtaniemi IT: Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J Clin Invest. 2000 Mar;105(5):633-41.
Pubmed: 10712435
|